PHILIPS RESPIRONICS
Respironics Inc. was acquired by Philips Holding USA Inc. Respironics, Inc. develops, manufactures, and distributes products for sleep and respiratory markets. It offers non-invasive ventilation systems, homecare pulse oximetry systems, oxygen concentrators, portable home ventilators, CPAP and BiPAP therapy devices, masks, diagnostic sleep systems, titration systems, screening devices, oral appliances, peak flow meters, spacer/holding chambers, nebulizers and compressors, and allergy products. The company offers its products through online. Respironics, Inc. was founded in 1976 and is headquartered in Murrysville, Pennsylvania.
PHILIPS RESPIRONICS
Industry:
Developer Platform Health Care Manufacturing
Founded:
1976-01-01
Address:
Philips, Florida, United States
Country:
United States
Website Url:
http://www.usa.philips.com
Total Employee:
1001+
Status:
Active
Contact:
1800 102 2929
Technology used in webpage:
SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Microsoft Exchange Online Amazon IPv6 Microsoft Azure DNS YouTube
Similar Organizations
Anika Therapeutics
Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its
DJO Global
DJO Global is a manufacturer and distributor of medical devices for musculoskeletal health, vascular health, and pain management.
Inogen
Inogen is a manufacturer and an accredited homecare provider dedicated to oxygen therapy.
Newest Events participated
Official Site Inspections
http://www.usa.philips.com
- Host name: ec2-3-251-19-161.eu-west-1.compute.amazonaws.com
- IP address: 3.251.19.161
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Philips Respironics" on Search Engine
Executive Committee | Philips
The Executive Committee operates under the chairmanship of the Chief Executive Officer and supports the Board of Management in the deployment of Philips' strategy and …See details»
Explained: Philips Respironics consent decree | Philips
On January 29, 2024, Philips announced that it agreed with the DOJ and FDA on the terms of the proposed consent decree. Philips’ subsidiaries Philips Holding USA and Philips …See details»
Philips Respironics agrees on consent decree | Philips
Apr 10, 2024 On January 29, 2024, Philips announced that it agreed with the DOJ and FDA on the terms of the proposed consent decree. Philips’ subsidiaries Philips Holding USA …See details»
Sleep and Respiratory Care | Philips
1. Select your area of interest. Philips Respironics, a global leader in the sleep and respiratory markets, is passionate about providing solutions that lead to healthier patients, healthier practices, and healthier businesses.See details»
Philips Respironics Sleep and Respiratory Care devices | Philips
Information for. clinicians ›. An update on our progress. Globally, we have remediated 99% of actionable* sleep therapy device registrations to date. As the remediation of the …See details»
About us | Philips
At Philips, our purpose is to improve people’s health and well-being through meaningful innovation. We aim to improve 2.5 billion lives per year by 2030, including 400 million in …See details»
Respironics - Wikipedia
Respironics is an American medical supply company owned by Philips that specializes in products that improve respiratory functions. It is based in the Pittsburgh suburb of …See details»
A conversation with David Ferguson, Business Leader, Sleep
Philips Respironics will continue with the remediation program. David Ferguson, Business Leader, Sleep & Respiratory Care, joined Philips in March 2021. Since then, he has led …See details»
The Philips Respironics consent decree provides a clear path …
Feb 27, 2024 This consent decree, which primarily focuses on Philips Respironics’ business operations in the US, provides a clear path forward with defined actions, …See details»
Philips Respironics
About Philips Respironics As a global leader in the sleep and respiratory markets, we're passionate about providing solutions that lead to healthier patients, practices, and …See details»
Patient safety and quality | Philips
Patient safety and quality is at the heart of everything we do, across all of Philips’ businesses. In 2023, we strengthened responsibility and accountability for patient safety …See details»
Our strategic focus | Philips
Additionally, we remain committed to rebuilding our position in Sleep & Respiratory Care while continuing to resolve the effects of the Respironics recall. Scalable patient- and …See details»
Breathing and respiratory care - Philips
Innovative, connected and patient-focused Respiratory Therapy and COPD solutions. Breathing and Respiratory Care. At Philips Respironics, we work in concert with care …See details»
Advancing Digital Health Technology | Philips
Services. Connect with us. Get in touch to learn how our innovative products and services can benefit your organization. Contact us. Sleep and respiratory recall . Access …See details»
Medical Device Recall Information - Philips Respironics Sleep and ...
Latest updates. Explained: The voluntary Philips Respironics sleep and respiratory care devices recall* * This is a voluntary recall notification in the US and field safety notice in …See details»
Advisory - Update on Philips Respironics recall of several models …
Jul 27, 2022 Health Canada is providing an update on the progress of Philips Respironics' (Philips) recall of several models of CPAP and BiLevel PAP machines and …See details»
Home | Philips Foundation
May 21, 2024 Philips Foundation 2023 Annual Report. Don't hesitate to contact us. Our mission at Philips Foundation is to reduce healthcare inequality by providing access to …See details»
Q4 2023 Quarterly report Philips delivers strong full-year results ...
Amsterdam, January 29, 2024. Delivers strong sales growth, improved profitability, and strong cash flow in 2023 through solid execution of first year of 2023-2025 plan. Agrees …See details»
Service solutions | Philips
Service solutions that help you. Philips is your partner committed to help improve your organization’s key performance indicators (KPIs), including clinical, operational, …See details»
Annual Report 2022 Financial performance - Philips Results
The year 2022. Sales amounted to EUR 17.8 billion, an increase of 4% on a nominal basis. On a comparable basis*), sales declined 3%, due to operational and supply challenges, …See details»